Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler

A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)

To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6 weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.

Inclusion Criteria:

• Asthma patients from both sexes, age 18 or older
• Have already been on Symbicort SMART treatment
• Willing to give written informed consents to participate in the program.

Exclusion Criteria:

• Patients who are not willing to give written informed consent
• Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.